X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38763) 38763
Patent (754) 754
Book Chapter (93) 93
Conference Proceeding (11) 11
Book / eBook (8) 8
Dissertation (6) 6
Newspaper Article (4) 4
Government Document (3) 3
Magazine Article (3) 3
Publication (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35784) 35784
animals (15559) 15559
cell line, tumor (8620) 8620
mice (7130) 7130
apoptosis (7107) 7107
male (7016) 7016
biochemistry & molecular biology (6728) 6728
female (6624) 6624
expression (6529) 6529
cancer (6349) 6349
oncology (6242) 6242
cell biology (5806) 5806
proteins (5261) 5261
gene expression (4596) 4596
cell line (4535) 4535
tumor cells, cultured (4144) 4144
research (3941) 3941
carcinoma, hepatocellular - pathology (3928) 3928
liver neoplasms - pathology (3888) 3888
liver (3869) 3869
carcinoma, hepatocellular - metabolism (3514) 3514
apoptosis - drug effects (3484) 3484
middle aged (3459) 3459
signal transduction (3351) 3351
health aspects (3324) 3324
cells (3308) 3308
rats (3301) 3301
analysis (3298) 3298
liver neoplasms - metabolism (3287) 3287
hep g2 cells (3270) 3270
research article (3137) 3137
activation (3127) 3127
pharmacology & pharmacy (3127) 3127
hepatocellular carcinoma (3083) 3083
adult (3022) 3022
gastroenterology & hepatology (2909) 2909
in-vitro (2803) 2803
liver cancer (2768) 2768
medicine (2668) 2668
cells, cultured (2654) 2654
physiological aspects (2648) 2648
hepatoma (2615) 2615
oxidative stress (2586) 2586
gene-expression (2544) 2544
multidisciplinary sciences (2526) 2526
transfection (2513) 2513
phosphorylation (2349) 2349
liver - metabolism (2346) 2346
carcinoma, hepatocellular - genetics (2335) 2335
cell proliferation - drug effects (2335) 2335
biology (2285) 2285
liver neoplasms - genetics (2283) 2283
cell proliferation (2281) 2281
genetic aspects (2276) 2276
aged (2273) 2273
metabolism (2236) 2236
molecular sequence data (2232) 2232
hepatocellular-carcinoma (2172) 2172
medicine, research & experimental (2166) 2166
antineoplastic agents - pharmacology (2159) 2159
kinases (2154) 2154
tumors (2114) 2114
inhibition (2108) 2108
base sequence (2104) 2104
metastasis (2044) 2044
virology (2029) 2029
growth (2024) 2024
cell survival - drug effects (1998) 1998
gene expression regulation, neoplastic (1979) 1979
life sciences (1975) 1975
dose-response relationship, drug (1946) 1946
protein (1915) 1915
blotting, western (1895) 1895
care and treatment (1880) 1880
cell cycle (1877) 1877
hepatitis (1871) 1871
rna, messenger - metabolism (1831) 1831
science (1826) 1826
rodents (1825) 1825
genes (1824) 1824
hepatocytes (1793) 1793
down-regulation (1754) 1754
toxicology (1742) 1742
rna (1730) 1730
digestive system diseases (1709) 1709
immunology (1707) 1707
rna, messenger - genetics (1638) 1638
proliferation (1636) 1636
cytotoxicity (1614) 1614
signal transduction - drug effects (1609) 1609
gene (1591) 1591
biochemistry (1585) 1585
review (1577) 1577
up-regulation (1577) 1577
enzymes (1571) 1571
viruses (1568) 1568
genetics & heredity (1524) 1524
mutation (1522) 1522
identification (1510) 1510
development and progression (1508) 1508
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (39285) 39285
Chinese (882) 882
Japanese (268) 268
French (92) 92
German (57) 57
Korean (21) 21
Russian (21) 21
Spanish (6) 6
Dutch (3) 3
Hungarian (3) 3
Danish (2) 2
Polish (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 2016, Volume 378, Issue 2, pp. 131 - 141
Highlights • Our research reveals that LPS, an important mediator in liver tumor environment, contributes to the maintenance of stemness in CD133+ CSCs. • The... 
Hematology, Oncology and Palliative Medicine | Lipopolysaccharide | Tumor microenvironment | Cancer stem cells | Stemness maintenance | Plasticity | MARKER | TUMOR-INITIATING CELLS | MATRIX METALLOPROTEINASES | HEPATOCELLULAR-CARCINOMA | INVASION | ONCOLOGY | PROMOTION | TUMORIGENESIS | CONTRIBUTES | EXPRESSION | PROGRESSION | Neoplastic Stem Cells - drug effects | Humans | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Drug Resistance, Neoplasm | Male | NF-kappa B - metabolism | Carcinoma, Hepatocellular - drug therapy | Transfection | Neoplastic Stem Cells - metabolism | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Carcinoma, Hepatocellular - genetics | Neoplastic Stem Cells - pathology | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacology | Cell Line | AC133 Antigen - genetics | Liver Neoplasms - genetics | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | Tumor Burden | Cell Movement - drug effects | Phenotype | Animals | Signal Transduction - drug effects | Mice, Nude | AC133 Antigen - metabolism | Carcinoma, Hepatocellular - pathology | Lipopolysaccharides - pharmacology | Liver Neoplasms - metabolism | Cell Proliferation - drug effects | Mice, Inbred BALB C | Carcinoma, Hepatocellular - metabolism
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e115577
Journal Article
Journal Article
Journal Article
Acta pharmacologica Sinica, ISSN 1671-4083, 2017, Volume 38, Issue 11, pp. 1486 - 1500
...), a novel resveratrol derivative in human liver cancer cells in vitro. Res-006 suppressed the viability of HepG2 human hepatoma cells more effectively than resveratrol... 
NAC | Resveratrol-006 | Mitochondria | HepG2 human hepatoma cells | 4-phenylbutyrate | Resveratrol | ROS | Mito-TEMPO | Apoptosis | Endoplasmic reticulum stress | OXIDATIVE STRESS | CANCER CELLS | mitochondria | apoptosis | ENDOPLASMIC-RETICULUM STRESS | MAMMALIAN-CELLS | CHEMISTRY, MULTIDISCIPLINARY | endoplasmic reticulum stress | resveratrol-006 | UNFOLDED PROTEIN RESPONSE | MESSENGER-RNA | PHARMACOLOGY & PHARMACY | resveratrol | TRANSCRIPTION FACTOR | MEMBRANE PERMEABILIZATION | TRANSMEMBRANE PROTEIN | Reactive Oxygen Species - metabolism | Endoplasmic Reticulum Stress - drug effects | Apoptosis - drug effects | Humans | Liver Neoplasms - drug therapy | Mitochondria - metabolism | Mitochondria - drug effects | Mitochondria - pathology | Stilbenes - pharmacology | Membrane Potential, Mitochondrial - drug effects | Hep G2 Cells | Dose-Response Relationship, Drug | Carcinoma, Hepatocellular - drug therapy | Time Factors | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Inhibitory Concentration 50 | Liver Neoplasms - pathology | Oxidative Stress - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Carcinoma, Hepatocellular - metabolism | Seeds | Nuts | Liver | Crosstalk | Cytology | Acetylcysteine | Hepatoma | Accumulation | Liver cancer | Membrane potential | Stresses | Peanuts | Mortality | Stress | trans-Stilbene | Grapes | Hepatocytes | Cell death | Pine | N-Acetyl-L-cysteine | Viability | Phenylbutyric acid | Cancer | Stilbene | Original
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 10, p. e0139790
Journal Article